Clinical Case Series - 23dlbcl - Question 2

When educating patients who are receiving first- or second-line therapies do you mention potential later-line therapies, or do you wait until the patient's disease has progressed?

I provide a potential roadmap for future therapies when initiating first-line therapy
I will mention later-line therapies once disease has progressed past first-line
I try to focus on each line of therapy as it happens
I will discuss later-line therapies in the first-line if the patient asks for information
{"name":"Clinical Case Series - 23dlbcl - Question 2", "url":"https://www.poll-maker.com/QN2UD3JDD","txt":"When educating patients who are receiving first- or second-line therapies do you mention potential later-line therapies, or do you wait until the patient's disease has progressed?","img":"https://www.poll-maker.com/3012/images/ogquiz.png"}